Véronique Bourdeau

6.0k citations

42 papers · 4.6k indexed · 2 hit papers · h-index 24

Aging top 2%
Pathology and Forensic Medicine top 1%
Microbiology top 1%
Cancer Research top 2%
Physiology top 2%
- Telomeres, Telomerase, and Senescence 6
Molecular Biology
- RNA modifications and cancer 8
- Retinoids in leukemia and cellular processes 7
- Ubiquitin and proteasome pathways 6
- Histone Deacetylase Inhibitors Research 6
- RNA and protein synthesis mechanisms 6
- Protein Degradation and Inhibitors 4
Oncology
- Cancer-related Molecular Pathways 8

Co-authors: Gerardo Ferbeyre John H. White Yoshihiko Nagai Sylvie Mader Luz E. Tavera-Mendoza Tiantian Wang Olga Moiseeva Xavier Deschênes‐Simard
Cited by: Aging Pathology and Forensic Medicine Microbiology
Partner nations: Canada United States Belgium

In The Last Decade

Véronique Bourdeau

41 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation
2004 Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression

Peers

Countries citing papers authored by Véronique Bourdeau

Since Specialization

Citations

This map shows the geographic impact of Véronique Bourdeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Bourdeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Bourdeau more than expected).

Fields of papers citing papers by Véronique Bourdeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Bourdeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Bourdeau. The network helps show where Véronique Bourdeau may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Véronique Bourdeau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Véronique Bourdeau Line = papers co-authored together Véronique Bourdeau links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A senescence restriction point acting on chromatin integrates oncogenic signals Stéphane Lopes‐Paciencia,Véronique Bourdeau,Marie‐Camille Rowell,Davoud Amirimehr,Jordan Guillon,Paloma Kalegari,Arnab Barua,Vincent Quoc‐Huy Trinh,Féryel Azzi,Simon Turcotte,Adrian W.R. Serohijos,Gerardo Ferbeyre	2024	4
2	Gaining Insight into Mitochondrial Targeting: AUTAC-Biguanide as an Anticancer Agent Julie Vatté,Véronique Bourdeau,Gerardo Ferbeyre,Andreea R. Schmitzer	2024	2
3	Effects of Biguanide-PROTACs in Pancreatic Cancer Cells Julie Vatté,Véronique Bourdeau,Gerardo Ferbeyre,Andreea R. Schmitzer	2024	0
4	Senescent Macrophages Release Inflammatory Cytokines and RNA-Loaded Extracellular Vesicles to Circumvent Fibroblast Senescence Camille Laliberté,Bianca Bossé,Véronique Bourdeau,Luis I. Prieto,Genève Perron-Deshaies,Nhung Vuong,Sebastian Igelmann,Lisbeth C. Aguilar,Marlene Oeffinger,Darren J. Baker,Luc DesGroseillers,Gerardo Ferbeyre	2024	7
5	Targeting ribosome biogenesis reinforces ERK-dependent senescence in pancreatic cancer MC. Rowell,Xavier Deschênes‐Simard,Stéphane Lopes‐Paciencia,Benjamin Le Calvé,Paloma Kalegari,Lian Mignacca,Ana Fernández Ruiz,Jordan Guillon,Frédéric Lessard,Véronique Bourdeau,Sebastian Igelmann,AM. Duman,Y. Stanom,Filippos Kottakis,Vikram Deshpande,Valery Krizhanovsky,Nabeel Bardeesy,Gerardo Ferbeyre	2023	8
6	The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells Maxime Parisotto,Nhung Vuong,Paloma Kalegari,Thulaj Meharwade,Loïck Joumier,Sebastian Igelmann,Véronique Bourdeau,Marie‐Camille Rowell,Michaël Pollak,Mohan Malleshaiah,Andreea R. Schmitzer,Gerardo Ferbeyre	2022	11
7	Zinc controls PML nuclear body formation through regulation of a paralog specific auto-inhibition in SUMO1 Mathieu Lussier-Price,Haytham M. Wahba,Xavier H. Mascle,Laurent Cappadocia,Véronique Bourdeau,Christina Gagnon,Sebastian Igelmann,Kazuyasu Sakaguchi,Gerardo Ferbeyre,James G. Omichinski	2022	8
8	Cellular senescence limits translational readthrough Neylen Del Toro,Frédéric Lessard,Jacob Bouchard,Nasrin Mobasheri,Jordan Guillon,Sebastian Igelmann,Sarah Tardif,Tony Buffard,Véronique Bourdeau,Léa Brakier‐Gingras,Gerardo Ferbeyre	2021	2
9	Phosphorylation of SOCS1 Inhibits the SOCS1–p53 Tumor Suppressor Axis Emmanuelle Saint‐Germain,Lian Mignacca,Geneviève Huot,Mariana Acevedo,Karine Moineau‐Vallée,Viviane Calabrese,Véronique Bourdeau,Marie‐Camille Rowell,Subburaj Ilangumaran,Frédéric Lessard,Gerardo Ferbeyre	2019	14
10	Circumventing senescence is associated with stem cell properties and metformin sensitivity Xavier Deschênes‐Simard,Maxime Parisotto,Marie‐Camille Rowell,Benjamin Le Calvé,Sebastian Igelmann,Karine Moineau‐Vallée,Emmanuelle Saint‐Germain,Paloma Kalegari,Véronique Bourdeau,Filippos Kottakis,Nabeel Bardeesy,Gerardo Ferbeyre	2019	34
11	Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway Frédéric Lessard,Sebastian Igelmann,Christian Trahan,Geneviève Huot,Emmanuelle Saint‐Germain,Lian Mignacca,Neylen Del Toro,Stéphane Lopes‐Paciencia,Benjamin Le Calvé,Marinieve Montero,Xavier Deschênes‐Simard,Marina Bury,Olga Moiseeva,Marie‐Camille Rowell,Cornelia E. Zorca,Daniel Zenklusen,Léa Brakier‐Gingras,Véronique Bourdeau,Marlene Oeffinger,Gerardo Ferbeyre	2018	111
12	A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence Mariana Acevedo,Mathieu Vernier,Lian Mignacca,Frédéric Lessard,Geneviève Huot,Olga Moiseeva,Véronique Bourdeau,Gerardo Ferbeyre	2016	48
13	STAT5A is regulated by DNA damage via the tumor suppressor p53 Utpal K. Mukhopadhyay,Jamaica Cass,Leda Raptis,Andrew W. Craig,Véronique Bourdeau,Sonal Varma,Sandip Sengupta,Bruce E. Elliott,Gerardo Ferbeyre	2016	8
14	CHES1/FOXN3 regulates cell proliferation by repressing PIM2 and protein biosynthesis Geneviève Huot,Mathieu Vernier,Véronique Bourdeau,Laurent Doucet,Emmanuelle Saint‐Germain,Marie‐France Gaumont‐Leclerc,Alejandro Moro,Gerardo Ferbeyre	2014	29
15	Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activationbreakdown → Olga Moiseeva,Xavier Deschênes‐Simard,Emmanuelle St‐Germain,Sebastian Igelmann,Geneviève Huot,Alexandra Elena Cadar,Véronique Bourdeau,Michaël Pollak,Gerardo Ferbeyre	2013	486
16	Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation Xavier Deschênes‐Simard,Marie‐France Gaumont‐Leclerc,Véronique Bourdeau,Frédéric Lessard,Olga Moiseeva,Valérie Forest,Sebastian Igelmann,Frédérick A. Mallette,Marc K. Saba-El-Leil,Sylvain Meloche,Fred Saad,Anne‐Marie Mes‐Masson,Gerardo Ferbeyre	2013	147
17	Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence Olga Moiseeva,Véronique Bourdeau,Antoine E. Roux,Xavier Deschênes‐Simard,Gerardo Ferbeyre	2009	298
18	Ligand-dependent Corepressor LCoR Is an Attenuator of Progesterone-regulated Gene Expression Ana Palijan,Isabelle Fernandes,Mark Verway,Maria Kourelis,Yolande Bastien,Luz E. Tavera-Mendoza,Aaron Sacheli,Véronique Bourdeau,Sylvie Mader,John H. White	2009	32
19	Cutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression Tiantian Wang,Frederick P. Nestel,Véronique Bourdeau,Yoshihiko Nagai,Qiuyu Wang,Jie Liao,Luz E. Tavera-Mendoza,Roberto Lin,John H. Hanrahan,Sylvie Mader,John H. White	2004	86
20	Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse Véronique Bourdeau,Julie Deschênes,Raphaël Métivier,Yoshihiko Nagai,Denis Nguyen,Nancy Bretschneider,Frank Gannon,John H. White,Sylvie Mader	2004	274

About Véronique Bourdeau

Véronique Bourdeau is a scholar working on Molecular Biology, Cancer Research and Oncology, having authored 42 papers that have together received 4.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer-related Molecular Pathways (8 papers), Retinoids in leukemia and cellular processes (7 papers), Ubiquitin and proteasome pathways (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Telomeres, Telomerase, and Senescence (6 papers), RNA and protein synthesis mechanisms (6 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Aging (139 citations), Pathology and Forensic Medicine (1.2k citations) and Microbiology (292 citations). Véronique Bourdeau has collaborated with scholars based in Canada, United States and Belgium. Frequent co-authors include Gerardo Ferbeyre, John H. White, Yoshihiko Nagai, Sylvie Mader, Luz E. Tavera-Mendoza, Tiantian Wang, Olga Moiseeva, Xavier Deschênes‐Simard, Frederick P. Nestel and Roberto Lin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact